Considerable effort has been made in recent years to evaluate—or in some cases, reevaluate—psychedelic drugs for potential use as therapeutics to treat, among other things, psychiatric disorders such…
Read More
Among those studying psychedelic drugs to treat psychiatric illnesses, there is new research exploring the possibility that structurally modified versions of these agents may reduce or eliminate…
Read More
In an exploratory and preliminary clinical test, a team of researchers at Stanford University has obtained “initial evidence” suggesting that a psychoactive compound called ibogaine, when co-…
Read More
